Delivery Order SPE2DR25D2010-SPE2DR26F4ZDM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,756.34 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors, with an ultimate completion date of December 9, 2025. This non-competitive, firm fixed-price delivery order was issued on December 8, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $6,801.60 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child delivery order under the company's larger indefinite delivery contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $8,886.71 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on December 3, 2025, with an ultimate completion date of December 4, 2025. This non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors with a ceiling value of $1,107.42 and an ultimate completion date of December 8, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,774.62 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on December 2, 2025, with a completion date of December 3, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply requirement for the federal healthcare system. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,927.33 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,430.68 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on December 3, 2025, with completion expected by December 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical supply transaction under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $22,358.72 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order is non-competitive and was issued without a set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $11,592.37 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $10,814.13 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors with a completion date of June 2, 2025. This non-set-aside competitive award represents a continuation of services under AmerisourceBergen's broader pharmaceutical supply arrangement with the federal government. The delivery order is being fulfilled from the company's place of business in Conshohocken,...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZDMDelivery Order
The Defense Logistics Agency awarded a $9,848.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. The contract, which is not set-aside, has an ultimate completion date of December 8, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. The award falls under the company's $999.99 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and provides comprehensive global pharmaceutical support for military healthcare programs. As a non-set-aside award, this delivery order demonstrates the contractor's continued capability to meet federal procurement requirements through open competition and reflects DLA's pharmaceutical supply chain strategy for supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 12/4/25 |